CAR T and Related Immune Effector Cell Therapies

Find presenter-approved materials from the ASGCT Pre-Meeting Workshop CAR T and Related Immune Effector Cell Therapies


The CAR T and Related Immune Effector Cell Therapies workshop features discussions of the current state of CAR T therapeutic approaches in light of recent FDA approvals with updates on clinical long term follow-up. This workshop includes sessions on gene editing and going beyond autologous CAR-T cells for cancer.

2019 Workshop Materials

CAR T and Related Immune Effector Cell Therapies

Saar Gill, M.D., Ph.D.—University of Pennsylvania

ASTCT Consensus Grading for CRS and ICANS

Sattva S. Neelapu, M.D.—The University of Texas MD Anderson Cancer Center

Factors impacting duration of response after CD19 CAR-T cells for adult B-cell ALL and NHL

Cameron Turtle, MBBS, Ph.D.—Fred Hutchinson Cancer Research Center

2019

ASGCT Policy Summit

November 4 – 6 | Washington D.C.